Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US

IMPORTANCE: Clinical trials and compassionate use agreements provide selected patients with access to potentially life-saving treatments before approval by the Food and Drug Administration (FDA). Approval from the FDA decreases a number of access barriers; however, it is unknown whether FDA approval...

Descripción completa

Detalles Bibliográficos
Autores principales: Ermer, Theresa, Canavan, Maureen E., Maduka, Richard C., Li, Andrew X., Salazar, Michelle C., Kaminski, Michael F., Pichert, Matthew D., Zhan, Peter L., Mase, Vincent, Kluger, Harriet, Boffa, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247736/
https://www.ncbi.nlm.nih.gov/pubmed/35771575
http://dx.doi.org/10.1001/jamanetworkopen.2022.19535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247736/
https://www.ncbi.nlm.nih.gov/pubmed/35771575
http://dx.doi.org/10.1001/jamanetworkopen.2022.19535

Ejemplares similares